Jamaica’s agriculture minister has dismissed claims that long-delayed laws for medical hashish exports is inflicting worldwide corporations to exit the nation.

Audley Shaw, minister of Industry, Commerce, Agriculture and Fisheries, mentioned license holders in Jamaica have had the ability to export hashish flower and extracts and medical and scientific use since November 2018.

Addressing Parliament about media reviews indicating a number of corporations had been “pulling out of Jamaica as a result of the failure of the CLA (Cannabis Licensing Authority) to implement the required import/export regulations,” Shaw mentioned: “Let me state categorically, that this is not so.”

“The facts are that licence holders in the medical cannabis industry are not hindered in their ability to export products from Jamaica,” he mentioned.

Shaw mentioned 15 export authorizations have been granted by the CLA.

“These exports have been for various purposes including research, medical purposes, cultivation and manufacturing of medical products,” he mentioned.

Permanent laws to facilitate the business export of medical hashish from Jamaica, supposed to make the nation’s companies aggressive on the worldwide stage, have been delayed for a while.

The CLA printed the interim import/export measures to its web site this spring, although the company mentioned the measures have been in place for over a yr.

In a written assertion to Marijuana Business Daily, the CLA mentioned the interim protocols do not preclude a licensee from exporting business portions.

“The CLA has no restrictions on the purpose so long as it is for medical, scientific or therapeutic purposes. This is in line with the Single Convention on Narcotic Drugs 1961 as amended by the 1972 Protocol,” the company mentioned by way of electronic mail.

Nether Shaw nor the CLA may say when the everlasting laws could be prepared.

A ultimate draft has been handed to the Ministry of Justice.

As of May 31, simply over 700 purposes for hashish enterprise licenses had been obtained by the Cannabis Licensing Authority.

Sixty-three have been issued, 23 are on the granted stage and 270 are conditionally authorized and are constructing out their services, Shaw mentioned.

Jamaica is amongst a rising variety of international locations hoping to capitalize on medical marijuana exports.

However, the marketplace for medical marijuana imports is comparatively small up to now.

And although it has seen regular progress in latest quarters, it’s nowhere close to the multibillion-dollar market typically touted by authorities officers and company executives – often Canadians.

For instance, in 2019 Canada exported 5,372.three liters of hashish oil merchandise and 4,996 kilograms of hashish flower, however Canadian companies have to date failed to convert these exports into essential sources of income.

And nearly all of these exports went to simply two markets, Germany and Australia, which themselves are ramping up their very own home manufacturing.

Alexandra Chong, CEO of the Jamaican medical hashish firm Jacana, recognized Canada as a possible import market when the corporate was based.

But “there has been no import of significant quantities into Canada,” she mentioned. “One has to ask themselves, why is a country that has been exporting to Europe and other countries not importing, especially when the standards and regulations outside Canada are often much stricter?”

“If a country is able to meet quality standards, then why isn’t it able to import into Canada. There has been no meaningful answer to that,” she mentioned.

Publicly-available information exhibits that Canada imported little or no hashish in 2019 for medical or scientific use.

“We know that Jamaican medical cannabis has strong appeal.”

Read the interim measures to facilitate the export of hashish right here.

Matt Lamers is Marijuana Business Daily’s worldwide editor, primarily based close to Toronto. He will be reached at [email protected].

Source link